Ledipasvir plus sofosbuvir: Hint of added benefit in certain patients
Monday, March 9, 2015 - 10:50
in Health & Medicine
Reviewers report that in genotype 1 chronic hepatitis C, data from a historical comparison showed an advantage in virologic response. For further patient groups, suitable data were lacking, they say.